Andrew Reaume
Directeur Général chez Melior Discovery, Inc.
Postes actifs de Andrew Reaume
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Melior Discovery, Inc.
 Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Directeur Général | 01/01/2005 | - |
| Fondateur | 01/01/2005 | - | |
| President | 01/01/2005 | - | |
Melior Pharmaceuticals I, Inc.
 Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Melior Pharmaceuticals I, Inc. operates as a clinical stage pharmaceutical company. The private company is based in Exton, PA. The company was founded in 2008 by Andrew G Reaume. | President | 01/12/2008 | - |
| Fondateur | 01/12/2008 | - | |
| Directeur Général | 01/12/2008 | - |
Historique de carrière de Andrew Reaume
Anciens postes connus de Andrew Reaume
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01/01/1993 | 01/01/1999 |
| ADHERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 09/09/2021 | - |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Formation de Andrew Reaume
| University of Pennsylvania | Masters Business Admin |
| University of Connecticut | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Chief Executive Officer | 3 |
| Founder | 3 |
| President | 3 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Commercial Services |
Melior Pharmaceuticals I, Inc.
Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Melior Pharmaceuticals I, Inc. operates as a clinical stage pharmaceutical company. The private company is based in Exton, PA. The company was founded in 2008 by Andrew G Reaume. | Health Technology |
- Bourse
- Insiders
- Andrew Reaume
- Expérience
